Reactome | Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring <i>MET</i> Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models

Schema > LiteratureReference > Entries

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models Show undefined attributes

author	[Person:9736023] Engstrom, LD [Person:9736160] Aranda, R [Person:9736225] Lee, M [Person:9736083] Tovar, EA [Person:9736251] Essenburg, CJ [Person:9736243] Madaj, Z [Person:9736021] Chiang, H [Person:9736275] Briere, D [Person:9736094] Hallin, J [Person:9736139] Lopez-Casas, PP [Person:9736037] Ba�os, N [Person:9736026] Menendez, C [Person:9657011] Hidalgo, M [Person:9736288] Tassell, V [Person:9736166] Chao, R [Person:9736236] Chudova, DI [Person:9646433] Lanman, RB [Person:9736158] Olson, P [Person:9736084] Bazhenova, L [Person:9736162] Patel, SP [Person:9736088] Graveel, C [Person:9648536] Nishino, M [Person:9702248] Shapiro, GI [Person:9713352] Peled, N [Person:9700367] Awad, MM [Person:8852956] J�nne, PA [Person:6800518] Christensen, JG
created	[InstanceEdit:9736264] Orlic-Milacic, Marija, 2021-07-06
dbId	9736276
displayName	Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models
journal	Clin Cancer Res
pages	6661-6672
pubMedIdentifier	28765324
schemaClass	LiteratureReference
title	Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models
url	http://www.ncbi.nlm.nih.gov/pubmed/28765324
volume	23
year	2017

Referrals

(literatureReference)

[Reaction:R-HSA-9735946] Anti-MET small tyrosine kinase inhibitors bind MET

(author)

© 2026 Reactome

Cite Us!